AI predicts cancer drug success in new 30-Patient trial
Knowledge-focused
Not yet recruiting
This study tests a new AI platform called xDRIVE that aims to predict which standard treatments will work for people with advanced colorectal cancer that has spread. About 30 adults will join, and researchers will check if the AI can correctly predict treatment response at least …
Sponsor: First Ascent Biomedical Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 03:15 UTC